Ranbaxy Laboratories Limited Stock

Stocks

End-of-day quote NSE India S.E. Other stock markets
- ^INR	-

16-03-07	UCB : Pharma crusader takes India's drug regulators to court	RE
15-06-28	Aurobindo Pharma : Indian pharma's struggle to tighten standards paves way for M&A deals	RE

16-03-07	UCB : Pharma crusader takes India's drug regulators to court	RE
15-06-28	Aurobindo Pharma : Indian pharma's struggle to tighten standards paves way for M&A deals	RE
15-04-20	DAIICHI SANKYO : Japan's Daiichi Sankyo to sell up to $3.6 billion Sun Pharma stake	RE
15-01-30	DAIICHI SANKYO : Sun Pharmaceutical wins U.S. approval to buy Ranbaxy	RE
14-12-05	AstraZeneca : Ranbaxy prevail in Nexium antitrust trial	RE
14-11-20	AstraZeneca : U.S. court denies Ranbaxy's bid to block launch of rival generics	RE
14-11-18	AstraZeneca : Ranbaxy sues FDA over revoking approvals for Nexium, Valcyte copies	RE
14-10-28	GlaxoSmithKline : Novartis results top forecasts as new products gain momentum	RE
14-07-31	AbbVie : AstraZeneca raises forecasts after seeing off Pfizer	RE
14-07-25	AbbVie : AstraZeneca results to get lift from bid foe Pfizer	RE
14-07-17	Novartis : Drugmaker Novartis to eke out more cost savings to lift margins	RE
14-06-24	Abbott India : Exclusive - India likely to extend price caps to more drugs: sources	RE
14-06-19	Mylan : EU to fine Servier, Teva for delaying generic drugs - sources	RE

15-03-04	Ranbaxy Laboratories : & APICON BREAK GUINNESS WORLD RECORD™	PU
15-01-28	Ranbaxy Laboratories : Q3FY 2015 Sales Rs.25,876Mn. YTD Dec’14 Sales Rs.81,778Mn	PU
14-12-06	Ranbaxy Laboratories : launches Red Heart Initiative to Raise Awareness on Women Heart Health	PU
14-12-01	Ranbaxy Laboratories : launches India’s first biosimilar of Infliximab drug, Infimab™	PU
14-07-29	Ranbaxy Laboratories : Q1 FY 2015 (Apr’14-Jun’14) Sales Rs.23.7 Bn	PU

14-07-17	Novartis : confirme l'objectif de croissance de ses ventes
14-07-17	Novartis : confirme l'objectif de croissance du C.A. annuel
14-06-19	Servier, Teva, d'autres à l'amende pour du "pay-for-delay"-sces
14-04-22	S& 500 : Vague de fusions dans le domaine de la pharmacie
14-04-07	Sun Pharmaceutical : Inde/Génériques-Sun Pharma acquiert Ranbaxy pour $3,2 mds

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
ELI LILLY AND COMPANY	+1.81%	+11.60%	+58.61%	+164.79%	1,097B
JOHNSON & JOHNSON	+1.51%	+11.77%	+69.61%	+57.53%	622B
ABBVIE INC.	+0.38%	+10.56%	+39.49%	+90.88%	449B
ROCHE HOLDING AG	-0.74%	+6.34%	+29.51%	+24.01%	334B
ASTRAZENECA PLC	+0.91%	+5.87%	+42.17%	+27.60%	294B
NOVARTIS AG	+1.09%	+3.13%	+32.35%	+41.42%	286B
NOVO NORDISK A/S	+1.22%	+3.44%	-27.58%	-42.09%	213B
AMGEN INC.	+0.62%	+4.59%	+30.10%	+63.03%	195B
GILEAD SCIENCES, INC.	-1.21%	+1.17%	+14.15%	+66.20%	157B
Average	+0.43%	+6.79%	+32.05%	+54.82%	405.19B
Weighted average by Cap.	+0.79%	+8.72%	+43.61%	+82.00%